Subcutaneous Tirzepatide Once-weekly in Patients With Obesity and Knee Osteoarthritis (STOP KNEE-OA)

NCT06191848 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

352

Enrollment

OTHER

Sponsor class

Conditions

Obesity
Knee Osteoarthritis
Osteoarthritis, Knee

Interventions

DRUG: Tirzepatide
DRUG: Placebo

Sponsor

University of Melbourne

Collaborators

[object Object]